Lowered expression of three of these genes (ASB2, NUDT10, and SRPX), as well as increased methylation of NRG1, was significantly correlated with lower recurrence-free survival in PCa patients, showing the utility of these TET2 targets as potential markers of disease. This evidence concerns the gene ASB2 and posterior cortical atrophy.